ログイン

Glycoside

Glycoside
70問 • 2年前
  • Quinn Karylle Fuentes
  • 通報

    問題一覧

  • 1

    A compound yield one or more. sugar among the product of hydrolysis.

    Glycosides.

  • 2

    A chemical composition of glucoside compose of sugar and connected into non sugar unit.

    Glycosides.

  • 3

    Digitalis llanata or digitalis purpurea

    Digitoxin.

  • 4

    From salix purpurea

    Salicin.

  • 5

    Prunus Armeniaca

    Prunasin.

  • 6

    When the sugar is glucose.

    Glucoside.

  • 7

    When the other sugar other yhan glucose is produced.

    Glycosides.

  • 8

    What are the component of glycosides

    Aglycone., Aglycon., Genin., Glycone.

  • 9

    A non sugar components

    Aglycon

  • 10

    Regulator, protective and sanitary function of plants.

    Glycosides.

  • 11

    The occurrence of glycosides are widely distributed into?

    Fruit, Seed, Leaves, Bark.

  • 12

    Phenol or OH group

    O-glycoside.

  • 13

    A group of a natural products characterized by their specific effect on myocardial contraction and atrioventricular contractions.

    Cardiac glycosides.

  • 14

    Cardiac glycosides is comprised of ?

    Steroidal aglycon., CPP.

  • 15

    Sugar component is attached on the 3 position of the CPP nucleus.

    Cardiac glycosides.

  • 16

    The moeity is attached to these two kind of non sugar components.

    2 aglycone

  • 17

    The sugar can midify tge activity, potency, toxicity, solubility and diffusion through membrane the rate id absorption and the transportation if glycosides.

    2 Aglycone.

  • 18

    Test the cardenolides and bufadienolides.

    Liebermann-burchard test.

  • 19

    A cardiac glycoside obtain from toad or frog.

    Bufadienolides.

  • 20

    Test the presence of lactone ring

    Kedde reaction.

  • 21

    The ability to increase the force of sytolic contractions.

    Inotropic effect.

  • 22

    Depletion of potassium ion increase digoxin toxicity.

    Inotropic effect.

  • 23

    An arrhythmogenic.

    Digitalis.

  • 24

    What are the source of digitalis.

    Foxglove (D.pururea), Grecian foxglove (D.lanta)

  • 25

    Digitalis contains 35 glycosides but the most important are

    Digitoxin, Digoxin, Gitoxin.

  • 26

    Which among of these are digitalis purpurea?

    Digitoxin., Gitoxin., Gitaloxin.

  • 27

    More commonly used because of ita polar and OH group in the structure.

    Digoxin.

  • 28

    Easily terminate therefore digoxin is short acting (T/F)

    True.

  • 29

    Used in the bioassay to determine the potency.

    Pigeon.

  • 30

    Digoxin inhibits Na-K-atpase which results to the increase of intercellular Cl ion concentration. (T/F)

    True.

  • 31

    They are not easily excreatable in the body that's why meron syang long half life and prone to toxicity.

    Digitoxin.

  • 32

    Digitoxin is the DOC for?

    Congestive heart failure., Arrhythmia, Atrial fibrillation.

  • 33

    Arrhythmia is a irregular heartbeat (T/F)

    True.

  • 34

    Used for rapid digitalization.

    Deslanoside.

  • 35

    What is the name of aglycone in digitoxin?

    Digitoxigenin.

  • 36

    If the lactone ring attached in 23 C therefore therefore it called as?

    Cardenolides.

  • 37

    Convallaria also know as?

    Lily of the valley.

  • 38

    Convallia are from

    Convallaria majalis.

  • 39

    What is the main components for convallaria

    Convallatoxin.

  • 40

    Apocynum also know as?

    Dog bane, Black indian hemp.

  • 41

    Apocynum is from?

    Apocynum cannabis.

  • 42

    The constituents of this are pharmacologically active cardenolides.

    Apocynum.

  • 43

    What is the main components present in apocynum.

    Cymarin.

  • 44

    These are Knows as pheasant eye

    Adonis.

  • 45

    Adonis is extracted from?

    Adonis vernalis.

  • 46

    What is the main components present in adonis.

    Adonitoxin., Cymarin, K-Strophanthin.

  • 47

    Cactus grandiflorus also know as?

    Night blooming cereus.

  • 48

    This is extracted from selenicerus grandiflorus.

    Cactus grandiflorus.

  • 49

    A mucilaginous and yield a sticky juice and form a viscid pulp when pounded in mortar

    Cactus grandiflorus.

  • 50

    A positive inotropic effect which can used for heart condition.

    Cactus grandiflorus.

  • 51

    Black hellebore also know as?

    Christmas rose.

  • 52

    Black shiney leaves with white flower

    Black hellebore.

  • 53

    What are the main component in black hellebore

    hellebrin, Hellebriginin, Helloborin

  • 54

    A potent narcotic with burning arcid taste

    Helleborine

  • 55

    Is a digitalic narcotic and said to posses anti carcinomic characteristic.

    Hellebrin.

  • 56

    Strophantus are extracted from?

    Strophantus Kombre, Strophantus Hispidus.

  • 57

    3rd most important glycoside available in the market

    K. strophanthin (oubain)

  • 58

    Squill bulb is extracted from?

    Urginea maritima

  • 59

    What is the main component of squill bulb

    Scillaren

  • 60

    Squill bulb used as expectorant and the red variety of this called rodenticide. (True/False)

    True.

  • 61

    The root of Dioscorea contain ?

    Diosgenin.

  • 62

    Diosgenin is obtain upon hydrolysis of dioscin.

    Diosgenin.

  • 63

    Ginseng is from the perennial herbs called?

    Panax quinquefolius, Panax ginseng.

  • 64

    Contain complwx mixture of triterpenoid. daponins that can be either steroidal triterpenes or pentacylic related to oleanolic acid.

    Ginseng.

  • 65

    Have both stimulatory and inhibitor effect on cns

    Ginenodised.

  • 66

    Use in the treatment of debility with old age or illness lack of appetite, insomia, stress, shock and chronic illness.

    Ginenosides.

  • 67

    One of tha major saponins found in ginseng.

    Ginsenoside.

  • 68

    What do you called a aglycone in. panaxoside

    Oleonolic acid

  • 69

    In consist of aglycone know as oleonolic acid.

    panaxosides.

  • 70

    Contains a large amount of starch gum some resin and very small amount of volatile oils.

    Chokusetsu saponins.

  • Cell structure.

    Cell structure.

    Quinn Karylle Fuentes · 28問 · 2年前

    Cell structure.

    Cell structure.

    28問 • 2年前
    Quinn Karylle Fuentes

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    Quinn Karylle Fuentes · 29問 · 2年前

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    29問 • 2年前
    Quinn Karylle Fuentes

    MW

    MW

    Quinn Karylle Fuentes · 45問 · 2年前

    MW

    MW

    45問 • 2年前
    Quinn Karylle Fuentes

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    Quinn Karylle Fuentes · 38問 · 2年前

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    38問 • 2年前
    Quinn Karylle Fuentes

    Density and specific gravity

    Density and specific gravity

    Quinn Karylle Fuentes · 34問 · 2年前

    Density and specific gravity

    Density and specific gravity

    34問 • 2年前
    Quinn Karylle Fuentes

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    Quinn Karylle Fuentes · 18問 · 2年前

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    18問 • 2年前
    Quinn Karylle Fuentes

    Microbial growth

    Microbial growth

    Quinn Karylle Fuentes · 63問 · 2年前

    Microbial growth

    Microbial growth

    63問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 61問 · 2年前

    Introduction.

    Introduction.

    61問 • 2年前
    Quinn Karylle Fuentes

    Microbial control.

    Microbial control.

    Quinn Karylle Fuentes · 97問 · 2年前

    Microbial control.

    Microbial control.

    97問 • 2年前
    Quinn Karylle Fuentes

    States of matter

    States of matter

    Quinn Karylle Fuentes · 100問 · 2年前

    States of matter

    States of matter

    100問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 86問 · 2年前

    Introduction.

    Introduction.

    86問 • 2年前
    Quinn Karylle Fuentes

    Drug development.

    Drug development.

    Quinn Karylle Fuentes · 77問 · 2年前

    Drug development.

    Drug development.

    77問 • 2年前
    Quinn Karylle Fuentes

    CGMP

    CGMP

    Quinn Karylle Fuentes · 9問 · 2年前

    CGMP

    CGMP

    9問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    Quinn Karylle Fuentes · 24問 · 2年前

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    24問 • 2年前
    Quinn Karylle Fuentes

    Powdered & granules

    Powdered & granules

    Quinn Karylle Fuentes · 43問 · 2年前

    Powdered & granules

    Powdered & granules

    43問 • 2年前
    Quinn Karylle Fuentes

    Capsule.

    Capsule.

    Quinn Karylle Fuentes · 24問 · 2年前

    Capsule.

    Capsule.

    24問 • 2年前
    Quinn Karylle Fuentes

    Tablets.

    Tablets.

    Quinn Karylle Fuentes · 23問 · 2年前

    Tablets.

    Tablets.

    23問 • 2年前
    Quinn Karylle Fuentes

    Calculatiom of dose

    Calculatiom of dose

    Quinn Karylle Fuentes · 3回閲覧 · 66問 · 2年前

    Calculatiom of dose

    Calculatiom of dose

    3回閲覧 • 66問 • 2年前
    Quinn Karylle Fuentes

    Postlab 5&6

    Postlab 5&6

    Quinn Karylle Fuentes · 29問 · 2年前

    Postlab 5&6

    Postlab 5&6

    29問 • 2年前
    Quinn Karylle Fuentes

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    Quinn Karylle Fuentes · 33問 · 2年前

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    33問 • 2年前
    Quinn Karylle Fuentes

    SEMI SOLID

    SEMI SOLID

    Quinn Karylle Fuentes · 69問 · 2年前

    SEMI SOLID

    SEMI SOLID

    69問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology

    Basic immunology

    Quinn Karylle Fuentes · 60問 · 2年前

    Basic immunology

    Basic immunology

    60問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology (2)

    Basic immunology (2)

    Quinn Karylle Fuentes · 62問 · 2年前

    Basic immunology (2)

    Basic immunology (2)

    62問 • 2年前
    Quinn Karylle Fuentes

    Transdermal

    Transdermal

    Quinn Karylle Fuentes · 44問 · 2年前

    Transdermal

    Transdermal

    44問 • 2年前
    Quinn Karylle Fuentes

    Distribution.

    Distribution.

    Quinn Karylle Fuentes · 43問 · 2年前

    Distribution.

    Distribution.

    43問 • 2年前
    Quinn Karylle Fuentes

    Infectious disease.

    Infectious disease.

    Quinn Karylle Fuentes · 65問 · 2年前

    Infectious disease.

    Infectious disease.

    65問 • 2年前
    Quinn Karylle Fuentes

    Infectious diseases (2)

    Infectious diseases (2)

    Quinn Karylle Fuentes · 79問 · 2年前

    Infectious diseases (2)

    Infectious diseases (2)

    79問 • 2年前
    Quinn Karylle Fuentes

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    Quinn Karylle Fuentes · 35問 · 2年前

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    Quinn Karylle Fuentes · 35問 · 2年前

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic ( Compressed)

    All topic ( Compressed)

    Quinn Karylle Fuentes · 30問 · 2年前

    All topic ( Compressed)

    All topic ( Compressed)

    30問 • 2年前
    Quinn Karylle Fuentes

    All topics (compressed)

    All topics (compressed)

    Quinn Karylle Fuentes · 13問 · 2年前

    All topics (compressed)

    All topics (compressed)

    13問 • 2年前
    Quinn Karylle Fuentes

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    Quinn Karylle Fuentes · 28問 · 2年前

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    28問 • 2年前
    Quinn Karylle Fuentes

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    Quinn Karylle Fuentes · 16問 · 2年前

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    16問 • 2年前
    Quinn Karylle Fuentes

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    Quinn Karylle Fuentes · 26問 · 2年前

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    26問 • 2年前
    Quinn Karylle Fuentes

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    Quinn Karylle Fuentes · 23問 · 2年前

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    23問 • 2年前
    Quinn Karylle Fuentes

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Quinn Karylle Fuentes · 35問 · 2年前

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    35問 • 2年前
    Quinn Karylle Fuentes

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    Quinn Karylle Fuentes · 20問 · 2年前

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    20問 • 2年前
    Quinn Karylle Fuentes

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    Quinn Karylle Fuentes · 33問 · 2年前

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    33問 • 2年前
    Quinn Karylle Fuentes

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    Quinn Karylle Fuentes · 37問 · 2年前

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    37問 • 2年前
    Quinn Karylle Fuentes

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    Quinn Karylle Fuentes · 23問 · 2年前

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    23問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae

    Enterobacteriaceae

    Quinn Karylle Fuentes · 35問 · 2年前

    Enterobacteriaceae

    Enterobacteriaceae

    35問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae.

    Enterobacteriaceae.

    Quinn Karylle Fuentes · 28問 · 2年前

    Enterobacteriaceae.

    Enterobacteriaceae.

    28問 • 2年前
    Quinn Karylle Fuentes

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    Quinn Karylle Fuentes · 31問 · 2年前

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    31問 • 2年前
    Quinn Karylle Fuentes

    Liquid dosage form

    Liquid dosage form

    Quinn Karylle Fuentes · 12問 · 2年前

    Liquid dosage form

    Liquid dosage form

    12問 • 2年前
    Quinn Karylle Fuentes

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    Quinn Karylle Fuentes · 44問 · 2年前

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    44問 • 2年前
    Quinn Karylle Fuentes

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    Quinn Karylle Fuentes · 22問 · 2年前

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    22問 • 2年前
    Quinn Karylle Fuentes

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    Quinn Karylle Fuentes · 40問 · 2年前

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    40問 • 2年前
    Quinn Karylle Fuentes

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    Quinn Karylle Fuentes · 29問 · 2年前

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    29問 • 2年前
    Quinn Karylle Fuentes

    Drug incompatibilities.

    Drug incompatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug incompatibilities.

    Drug incompatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    Drug compatibilities.

    Drug compatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug compatibilities.

    Drug compatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 35問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    35問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 30問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    30問 • 2年前
    Quinn Karylle Fuentes

    SUSPENSION.

    SUSPENSION.

    Quinn Karylle Fuentes · 45問 · 2年前

    SUSPENSION.

    SUSPENSION.

    45問 • 2年前
    Quinn Karylle Fuentes

    Colloidal.

    Colloidal.

    Quinn Karylle Fuentes · 40問 · 2年前

    Colloidal.

    Colloidal.

    40問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    Quinn Karylle Fuentes · 38問 · 2年前

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    38問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY.

    BACTERIOLOGY.

    Quinn Karylle Fuentes · 44問 · 2年前

    BACTERIOLOGY.

    BACTERIOLOGY.

    44問 • 2年前
    Quinn Karylle Fuentes

    Emulsion.

    Emulsion.

    Quinn Karylle Fuentes · 32問 · 2年前

    Emulsion.

    Emulsion.

    32問 • 2年前
    Quinn Karylle Fuentes

    EMULSION

    EMULSION

    Quinn Karylle Fuentes · 42問 · 2年前

    EMULSION

    EMULSION

    42問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    Quinn Karylle Fuentes · 36問 · 2年前

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    36問 • 2年前
    Quinn Karylle Fuentes

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    Quinn Karylle Fuentes · 33問 · 2年前

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    33問 • 2年前
    Quinn Karylle Fuentes

    Mycology.

    Mycology.

    Quinn Karylle Fuentes · 30問 · 2年前

    Mycology.

    Mycology.

    30問 • 2年前
    Quinn Karylle Fuentes

    Mycology 2.0

    Mycology 2.0

    Quinn Karylle Fuentes · 34問 · 2年前

    Mycology 2.0

    Mycology 2.0

    34問 • 2年前
    Quinn Karylle Fuentes

    m

    m

    Quinn Karylle Fuentes · 15問 · 2年前

    m

    m

    15問 • 2年前
    Quinn Karylle Fuentes

    ppr

    ppr

    Quinn Karylle Fuentes · 25問 · 2年前

    ppr

    ppr

    25問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    Quinn Karylle Fuentes · 20問 · 2年前

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    20問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    Quinn Karylle Fuentes · 86問 · 2年前

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    86問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    Quinn Karylle Fuentes · 100問 · 2年前

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    100問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    Quinn Karylle Fuentes · 19問 · 2年前

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    19問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 17問 · 2年前

    Introduction.

    Introduction.

    17問 • 2年前
    Quinn Karylle Fuentes

    Introduction of biochemistry

    Introduction of biochemistry

    Quinn Karylle Fuentes · 76問 · 2年前

    Introduction of biochemistry

    Introduction of biochemistry

    76問 • 2年前
    Quinn Karylle Fuentes

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    Quinn Karylle Fuentes · 56問 · 2年前

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    56問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 75問 · 2年前

    Carbohydrates

    Carbohydrates

    75問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates 1.1

    Carbohydrates 1.1

    Quinn Karylle Fuentes · 31問 · 2年前

    Carbohydrates 1.1

    Carbohydrates 1.1

    31問 • 2年前
    Quinn Karylle Fuentes

    Detect and quality variation.

    Detect and quality variation.

    Quinn Karylle Fuentes · 56問 · 2年前

    Detect and quality variation.

    Detect and quality variation.

    56問 • 2年前
    Quinn Karylle Fuentes

    INTRODUCTION

    INTRODUCTION

    Quinn Karylle Fuentes · 98問 · 2年前

    INTRODUCTION

    INTRODUCTION

    98問 • 2年前
    Quinn Karylle Fuentes

    lab (1-2)

    lab (1-2)

    Quinn Karylle Fuentes · 15問 · 2年前

    lab (1-2)

    lab (1-2)

    15問 • 2年前
    Quinn Karylle Fuentes

    lab 1-2

    lab 1-2

    Quinn Karylle Fuentes · 14問 · 2年前

    lab 1-2

    lab 1-2

    14問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    Quinn Karylle Fuentes · 45問 · 2年前

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    45問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    Quinn Karylle Fuentes · 35問 · 2年前

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    35問 • 2年前
    Quinn Karylle Fuentes

    Unit 3.

    Unit 3.

    Quinn Karylle Fuentes · 39問 · 2年前

    Unit 3.

    Unit 3.

    39問 • 2年前
    Quinn Karylle Fuentes

    Histamin and kinins

    Histamin and kinins

    Quinn Karylle Fuentes · 70問 · 2年前

    Histamin and kinins

    Histamin and kinins

    70問 • 2年前
    Quinn Karylle Fuentes

    PUD.

    PUD.

    Quinn Karylle Fuentes · 45問 · 2年前

    PUD.

    PUD.

    45問 • 2年前
    Quinn Karylle Fuentes

    ..

    ..

    Quinn Karylle Fuentes · 61問 · 2年前

    ..

    ..

    61問 • 2年前
    Quinn Karylle Fuentes

    Lipids.

    Lipids.

    Quinn Karylle Fuentes · 67問 · 2年前

    Lipids.

    Lipids.

    67問 • 2年前
    Quinn Karylle Fuentes

    lipids.

    lipids.

    Quinn Karylle Fuentes · 71問 · 2年前

    lipids.

    lipids.

    71問 • 2年前
    Quinn Karylle Fuentes

    LAB ✨

    LAB ✨

    Quinn Karylle Fuentes · 93問 · 2年前

    LAB ✨

    LAB ✨

    93問 • 2年前
    Quinn Karylle Fuentes

    Drug discovery.

    Drug discovery.

    Quinn Karylle Fuentes · 87問 · 2年前

    Drug discovery.

    Drug discovery.

    87問 • 2年前
    Quinn Karylle Fuentes

    disease of lipids.

    disease of lipids.

    Quinn Karylle Fuentes · 13問 · 2年前

    disease of lipids.

    disease of lipids.

    13問 • 2年前
    Quinn Karylle Fuentes

    Intro (identify structure)

    Intro (identify structure)

    Quinn Karylle Fuentes · 57問 · 2年前

    Intro (identify structure)

    Intro (identify structure)

    57問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 98問 · 2年前

    Carbohydrates

    Carbohydrates

    98問 • 2年前
    Quinn Karylle Fuentes

    Dynamic.

    Dynamic.

    Quinn Karylle Fuentes · 96問 · 2年前

    Dynamic.

    Dynamic.

    96問 • 2年前
    Quinn Karylle Fuentes

    Unit 1

    Unit 1

    Quinn Karylle Fuentes · 32問 · 2年前

    Unit 1

    Unit 1

    32問 • 2年前
    Quinn Karylle Fuentes

    問題一覧

  • 1

    A compound yield one or more. sugar among the product of hydrolysis.

    Glycosides.

  • 2

    A chemical composition of glucoside compose of sugar and connected into non sugar unit.

    Glycosides.

  • 3

    Digitalis llanata or digitalis purpurea

    Digitoxin.

  • 4

    From salix purpurea

    Salicin.

  • 5

    Prunus Armeniaca

    Prunasin.

  • 6

    When the sugar is glucose.

    Glucoside.

  • 7

    When the other sugar other yhan glucose is produced.

    Glycosides.

  • 8

    What are the component of glycosides

    Aglycone., Aglycon., Genin., Glycone.

  • 9

    A non sugar components

    Aglycon

  • 10

    Regulator, protective and sanitary function of plants.

    Glycosides.

  • 11

    The occurrence of glycosides are widely distributed into?

    Fruit, Seed, Leaves, Bark.

  • 12

    Phenol or OH group

    O-glycoside.

  • 13

    A group of a natural products characterized by their specific effect on myocardial contraction and atrioventricular contractions.

    Cardiac glycosides.

  • 14

    Cardiac glycosides is comprised of ?

    Steroidal aglycon., CPP.

  • 15

    Sugar component is attached on the 3 position of the CPP nucleus.

    Cardiac glycosides.

  • 16

    The moeity is attached to these two kind of non sugar components.

    2 aglycone

  • 17

    The sugar can midify tge activity, potency, toxicity, solubility and diffusion through membrane the rate id absorption and the transportation if glycosides.

    2 Aglycone.

  • 18

    Test the cardenolides and bufadienolides.

    Liebermann-burchard test.

  • 19

    A cardiac glycoside obtain from toad or frog.

    Bufadienolides.

  • 20

    Test the presence of lactone ring

    Kedde reaction.

  • 21

    The ability to increase the force of sytolic contractions.

    Inotropic effect.

  • 22

    Depletion of potassium ion increase digoxin toxicity.

    Inotropic effect.

  • 23

    An arrhythmogenic.

    Digitalis.

  • 24

    What are the source of digitalis.

    Foxglove (D.pururea), Grecian foxglove (D.lanta)

  • 25

    Digitalis contains 35 glycosides but the most important are

    Digitoxin, Digoxin, Gitoxin.

  • 26

    Which among of these are digitalis purpurea?

    Digitoxin., Gitoxin., Gitaloxin.

  • 27

    More commonly used because of ita polar and OH group in the structure.

    Digoxin.

  • 28

    Easily terminate therefore digoxin is short acting (T/F)

    True.

  • 29

    Used in the bioassay to determine the potency.

    Pigeon.

  • 30

    Digoxin inhibits Na-K-atpase which results to the increase of intercellular Cl ion concentration. (T/F)

    True.

  • 31

    They are not easily excreatable in the body that's why meron syang long half life and prone to toxicity.

    Digitoxin.

  • 32

    Digitoxin is the DOC for?

    Congestive heart failure., Arrhythmia, Atrial fibrillation.

  • 33

    Arrhythmia is a irregular heartbeat (T/F)

    True.

  • 34

    Used for rapid digitalization.

    Deslanoside.

  • 35

    What is the name of aglycone in digitoxin?

    Digitoxigenin.

  • 36

    If the lactone ring attached in 23 C therefore therefore it called as?

    Cardenolides.

  • 37

    Convallaria also know as?

    Lily of the valley.

  • 38

    Convallia are from

    Convallaria majalis.

  • 39

    What is the main components for convallaria

    Convallatoxin.

  • 40

    Apocynum also know as?

    Dog bane, Black indian hemp.

  • 41

    Apocynum is from?

    Apocynum cannabis.

  • 42

    The constituents of this are pharmacologically active cardenolides.

    Apocynum.

  • 43

    What is the main components present in apocynum.

    Cymarin.

  • 44

    These are Knows as pheasant eye

    Adonis.

  • 45

    Adonis is extracted from?

    Adonis vernalis.

  • 46

    What is the main components present in adonis.

    Adonitoxin., Cymarin, K-Strophanthin.

  • 47

    Cactus grandiflorus also know as?

    Night blooming cereus.

  • 48

    This is extracted from selenicerus grandiflorus.

    Cactus grandiflorus.

  • 49

    A mucilaginous and yield a sticky juice and form a viscid pulp when pounded in mortar

    Cactus grandiflorus.

  • 50

    A positive inotropic effect which can used for heart condition.

    Cactus grandiflorus.

  • 51

    Black hellebore also know as?

    Christmas rose.

  • 52

    Black shiney leaves with white flower

    Black hellebore.

  • 53

    What are the main component in black hellebore

    hellebrin, Hellebriginin, Helloborin

  • 54

    A potent narcotic with burning arcid taste

    Helleborine

  • 55

    Is a digitalic narcotic and said to posses anti carcinomic characteristic.

    Hellebrin.

  • 56

    Strophantus are extracted from?

    Strophantus Kombre, Strophantus Hispidus.

  • 57

    3rd most important glycoside available in the market

    K. strophanthin (oubain)

  • 58

    Squill bulb is extracted from?

    Urginea maritima

  • 59

    What is the main component of squill bulb

    Scillaren

  • 60

    Squill bulb used as expectorant and the red variety of this called rodenticide. (True/False)

    True.

  • 61

    The root of Dioscorea contain ?

    Diosgenin.

  • 62

    Diosgenin is obtain upon hydrolysis of dioscin.

    Diosgenin.

  • 63

    Ginseng is from the perennial herbs called?

    Panax quinquefolius, Panax ginseng.

  • 64

    Contain complwx mixture of triterpenoid. daponins that can be either steroidal triterpenes or pentacylic related to oleanolic acid.

    Ginseng.

  • 65

    Have both stimulatory and inhibitor effect on cns

    Ginenodised.

  • 66

    Use in the treatment of debility with old age or illness lack of appetite, insomia, stress, shock and chronic illness.

    Ginenosides.

  • 67

    One of tha major saponins found in ginseng.

    Ginsenoside.

  • 68

    What do you called a aglycone in. panaxoside

    Oleonolic acid

  • 69

    In consist of aglycone know as oleonolic acid.

    panaxosides.

  • 70

    Contains a large amount of starch gum some resin and very small amount of volatile oils.

    Chokusetsu saponins.